The Polycythemia Vera Channel

Explore the latest updates and expert interviews

Welcome to The Polycythemia Vera (PV) Channel

VJHemOnc is pleased to present The Polycythemia Vera Channel, featuring interviews, podcasts, and expert-led roundtable discussions on the latest advances in this rare blood disorder.

The treatment landscape of PV has expanded to include ruxolitinib, however several investigational agents including ropeginterferon, bulsufan and hydroxyurea have demonstrated efficacy in high-risk patients with PV.

Explore the latest trial updates in PV with The Polycythemia Vera Channel, brought to you by VJHemOnc.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter